MARKET

TMO

TMO

Thermo Fishr Sci
NYSE
491.60
-3.74
-0.76%
Closed 16:32 12/05 EST
OPEN
492.97
PREV CLOSE
495.34
HIGH
493.63
LOW
487.06
VOLUME
1.61M
TURNOVER
0
52 WEEK HIGH
609.85
52 WEEK LOW
415.60
MARKET CAP
189.94B
P/E (TTM)
32.19
1D
5D
1M
3M
1Y
5Y
Thermo Fisher Enters 15-yr Virtual Power Purchasing Agreement With Ib Vogt
NASDAQ · 1d ago
Thermo Fisher Scientific Establishes 2030 Renewable Electricity Goal and Solar Power Purchase Agreement with ib vogt
Thermo fisher scientific announces a 15-year virtual power purchasing agreement with ib vogt. The agreement will deliver 192,000 megawatt hours of renewable electricity annually. The serbal solar project is expected to be operational in january 2025. Thermo fisher's 91-megawatt portion of the solar project will be 100% renewable.
Benzinga · 1d ago
Thermo Fishr Sci: Current report
Press release · 1d ago
Thermo Fisher Scientific: Acquiring And Disappointing At The Same Time
Thermo fisher scientific inc. Continues to pursue acquisitions to add to its growing portfolio. The company's current operating performance is soft, with organic sales growth coming to a standstill. Thermo fisher's earnings guidance has been cut by around 10%, leading to a lower valuation and a cautious investment approach. The life science giant's growth was boosted by the pandemic, but pandemic-related trends are fading.
Seeking Alpha · 1d ago
SPYG, TMO, PFE, DHR: ETF Inflow Alert
NASDAQ · 1d ago
Goldman Sachs: Top 30 mutual fund underweight holdings, including Apple and Tesla
Goldman sachs: top 30 mutual fund underweight holdings, including apple and tesla. Goldman sachs analyzed $5 trillion of equity positions at the start of 4q 2023. The investment bank listed the stocks it was most underweight in its hedge fund trend monitor and mutual fundamentals reports.
Seeking Alpha · 1d ago
Thermo Fisher Scientific: Normalization Confirmed, In Search Of Growth Drivers
Thermo fisher scientific has normalized its growth spurred by the pandemic boom. It has made progress in paying down its high level debt and pulling up its cash-at-hand. Its revenue is still at all-time high levels, but its margins are mostly back to pre-pandemic levels. The company is on a path to normalize growth normalizing from the boom. M&a is an integrated part of its growth strategy.
Seeking Alpha · 2d ago
Thermo Fisher (TMO) Advances Health Equity via New Partnership
NASDAQ · 3d ago
More
About TMO
Thermo Fisher Scientific Inc. is engaged in serving science. The Company’s Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of infection and disease. The Analytical Instruments segment provides an offering of instruments and the supporting consumables, software and services that are used for a range of applications. The Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments, and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial and food safety laboratories. The Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory. Its brands include Thermo Scientific, Applied Biosystems, and others. It also provides regulatory-grade, real-world evidence for approved medical treatments and therapies.

Webull offers Thermo Fisher Scientific Inc stock information, including NYSE: TMO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TMO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TMO stock methods without spending real money on the virtual paper trading platform.